1. Home
  2. VKTX vs SSL Comparison

VKTX vs SSL Comparison

Compare VKTX & SSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • SSL
  • Stock Information
  • Founded
  • VKTX 2012
  • SSL 1950
  • Country
  • VKTX United States
  • SSL South Africa
  • Employees
  • VKTX N/A
  • SSL N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • SSL Oil & Gas Production
  • Sector
  • VKTX Health Care
  • SSL Energy
  • Exchange
  • VKTX Nasdaq
  • SSL Nasdaq
  • Market Cap
  • VKTX 3.4B
  • SSL 2.9B
  • IPO Year
  • VKTX 2015
  • SSL N/A
  • Fundamental
  • Price
  • VKTX $24.15
  • SSL $4.24
  • Analyst Decision
  • VKTX Strong Buy
  • SSL
  • Analyst Count
  • VKTX 11
  • SSL 0
  • Target Price
  • VKTX $95.18
  • SSL N/A
  • AVG Volume (30 Days)
  • VKTX 3.8M
  • SSL 787.9K
  • Earning Date
  • VKTX 04-23-2025
  • SSL 01-01-0001
  • Dividend Yield
  • VKTX N/A
  • SSL N/A
  • EPS Growth
  • VKTX N/A
  • SSL N/A
  • EPS
  • VKTX N/A
  • SSL N/A
  • Revenue
  • VKTX N/A
  • SSL $13,819,021,376.00
  • Revenue This Year
  • VKTX N/A
  • SSL N/A
  • Revenue Next Year
  • VKTX N/A
  • SSL $5.80
  • P/E Ratio
  • VKTX N/A
  • SSL N/A
  • Revenue Growth
  • VKTX N/A
  • SSL N/A
  • 52 Week Low
  • VKTX $23.27
  • SSL $4.04
  • 52 Week High
  • VKTX $82.00
  • SSL $9.33
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 33.93
  • SSL 47.28
  • Support Level
  • VKTX $25.80
  • SSL $4.06
  • Resistance Level
  • VKTX $29.60
  • SSL $4.41
  • Average True Range (ATR)
  • VKTX 1.61
  • SSL 0.09
  • MACD
  • VKTX -0.30
  • SSL 0.01
  • Stochastic Oscillator
  • VKTX 10.72
  • SSL 43.75

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main segments: Energy business and Chemical business. It generates maximum revenue from the Chemicals segment. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Sasol markets commodity and performance chemicals, sells liquid fuel products, and markets, distributes and transports pipeline gas. Geographically the company generates the majority of its revenue from South Africa.

Share on Social Networks: